228760.KS KSC
Genomictree Inc
1W: +1.9%
1M: -22.0%
3M: +51.1%
1Y: +27.4%
3Y: -7.3%
5Y: -24.6%
₩21,100.00
Last traded 2024-08-14 — delisted
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$13.6B
-25.3% ▼
Capital Expenditures
$2.6B
-785.0% ▼
5Y CAGR: +0.3%
Free Cash Flow
-$16.2B
-44.9% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$19.0B
+16.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$11.7B | -$11.4B | -$6.2B | -$9.0B | -$10.4B |
| Depreciation & Amort. | $908M | $1.0B | $1.3B | $1.2B | $1.2B |
| Stock-Based Comp. | $402M | $694M | $250M | $1.6B | $1.9B |
| Change in Working Capital | -$1.3B | -$741M | -$1.9B | -$1.5B | -$2.8B |
| Other Non-Cash Items | $784M | $3.7B | $10.8B | -$6.5B | -$3.6B |
| Operating Cash Flow | -$10.2B | -$7.6B | $4.3B | -$10.9B | -$13.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$2.8B | -$11.8B | -$1.8B | -$288M | -$2.5B |
| Acquisitions (Net) | $781M | $0 | $0 | $0 | $0 |
| Investment Purchases | -$1.0B | -$41.8B | -$19.4B | $0 | -$11.9B |
| Investment Sales | $14.7B | $0 | $32.9B | $5.5B | $0 |
| Other Investing | $2.6B | $4.5B | $2.4B | $2.9B | $2.9B |
| Investing Cash Flow | $14.3B | -$49.1B | $14.1B | $8.1B | -$11.5B |
| — Financing Activities — | |||||
| Net Debt Issuance | $13.1B | $48.2B | -$14.3B | $0 | $0 |
| Stock Repurchased | $0 | $0 | -$5.0B | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$168M | -$242M | -$258M | -$20.5B | $6.0B |
| Financing Cash Flow | $13.0B | $62.9B | -$19.5B | -$20.5B | $6.0B |
| Net Change in Cash | $13.7B | $9.8B | $1.1B | -$22.9B | -$19.0B |
| Cash End of Period | $56.6B | $66.5B | $67.6B | $45.3B | $26.4B |
| Free Cash Flow | -$13.0B | -$19.5B | $2.5B | -$11.2B | -$16.2B |